Efeitos da suplementação oral de zinco sobre o crescimento de crianças pré-púberes saudáveis e eutróficas

Introdução: o zinco é um importante micronutriente para numerosos processos bioquímicos em animais e humanos, desempenhando papel de destaque no crescimento e desenvolvimento. Em populações mundiais, a deficiência primária grave de zinco não é comum, embora, a deficiência leve seja bastante prevalente. Considerando que o zinco é essencial para a saúde humana e regula o sistema hipotálamo, hipófise, fígado e osso, buscamos averiguar os seus efeitos no eixo GH-IGF1-IGFBP3 agudamente, mediante administração intravenosa com o elemento zinco, e cronicamente, mediante suplementação oral com o elemento zinco, usando doses fisiológicas de 0.06537 mg Zn/kg (via intravenosa) e 10 mg Zn/dia (via oral). A inclusão de crianças pré-púberes aparentemente saudáveis e eutróficas sem deficiência de zinco é raro na literatura, pois grande parte das publicações foram reportadas em crianças apresentando deficiência de zinco. A metodologia aplicada foi absolutamente inovadora e original, tornando o estudo altamente relevante para a interface entre endocrinologia e nutrição. Objetivo: investigar os efeitos da suplementação oral e administração intravenosa com o elemento zinco sobre a secreção de GH, IGF1, IGFBP3, OCN, ALP, TRAP e PT em crianças aparentemente saudáveis e eutróficas sem deficiência de zinco. Métodos: o estudo foi conduzido durante um período de três meses, e caracterizado por ser randomizado controlado triplo cego. As crianças foram selecionadas por amostragem não probabilística de conveniência, provenientes de escolas públicas municipais, de ambos os gêneros, na faixa etária compreendida entre 8 e 9 anos de idade, divididas em grupo controle (20 crianças recebendo solução placebo contendo 10% de sorbitol) e grupo experimental (20 crianças suplementadas com o elemento zinco na forma de sulfato de zinco heptahidratado – ZnSO4.7H2O). As crianças foram submetidas à suplementação oral de zinco elementar (10 mg Zn/dia) e à administração intravenosa de zinco (0.06537 mg Zn/kg de peso corporal), na forma de ZnSO4.7H2O, cujas amostras sanguíneas foram coletadas em 0, 60, 120, 180 e 210 minutos. Foram realizadas avaliações antropométricas e dietéticas e dosagens bioquímicas e hormonais nas crianças estudadas. Resultados: após a suplementação oral, foi observado no grupo experimental (i) aumento significativo dos valores de ingestão de energia total, proteína e gordura total (p = 0.0007, p< 0.0001, p< 0.0001, respectivamente), (ii) aumento significativo do zinco sérico basal (p< 0.0001), aumento significativo das concentrações plasmáticas de fostatase alcalina (p = 0.0270), e (iv) correlação positiva com o IGF1, IGFBP3, OCN, comparando antes e após a suplementação (p = 0.0011, p< 0.0001, p< 0.0446, respectivamente). Durante a administração venosa de zinco, as concentrações plasmáticas de IGF1 e IGFBP3 aumentaram significativamente no grupo experimental (p = 0.0468, p < 0.0001, respectivamente). Em relação o cálculo da adequação aparente, segundo as DRI, para o cálcio, houve inadequação da dieta com 85% de confiabilidade dos dados; para o ferro, adequação da dieta, com 85% de confiabilidade dos dados. Para o zinco, adequação da dieta, com 50% de confiabilidade dos dados. Conclusões: a suplementação oral com o elemento zinco pode ter estimulado um aumento na ingestão de energia total, proteína e gordura total, assim como, nas concentrações basais de zinco sérico e nas concentrações plasmáticas de fosfatase alcalina. A administração intravenosa de zinco aumentou as concentrações séricas de zinco e as concentrações plasmáticas de GH, IGF1 e IGFBP3 no grupo experimental.

Efeitos da senescência no folheto intergeniculado do tálamo de ratos: análises morfológicas e neuroquímicas

The circadian timing system (CTS), in rodents, consists of interconnected neural structures such as the suprachiasmatic nucleus (SCN) of the hypothalamus, Intergeniculate Leaflet (IGL) of the thalamus, synchronous pathways and behavioral effectors. The SCN has been described as the major circadian pacemaker in several species of mammals, while the IGL appears to be involved in integration of photic and non-photic clues relaying them to SCN. The CTS allows an ordered internal temporal organization to the organism, providing the proper execution of physiological and behavioral mechanisms, which brings homeostasis. However, this stability is disrupted with aging process causing numerous pathological disorders, ranging from simple loss of physiological functions to decreases in cognitive performance. Therefore, is fundamental understanding the effects of senescence in this system. In this context, is proposed in this study to check if there are changes in IGL cytoarchitecture, neurochemical and retinal afferent markers with aging and their possible morpho-functional implications. To achieve this goal wistar rats were divided into 3 groups: young (3 months); Middle Age (13 months); Old (23 months). They were submitted to paraformaldhyde (4%) transcardiac perfusion to tissue fixation. Then, they had their brain removed and sectioned in 30 µm slices, which every sixth section were collected. This sections were processed by nissl method and immunostaining for GFAP, GAD, ENK, NPY and CTb in order to analyze the IGL features. It was observed a cell loss in middle age and old animals at Nissl, NPY and CTb stains. In addition, it was shown a increase in GFAP in middle aged animals compared to young and old ones. No differences were found in other neurochemichal stains. These data suggests IGL loss retinal afferents and neurons, in special the NPY-IR ones, likely having a compensatory gliogenesis. This supports the correlations between the CTS functional deficits and an anatomical deterioration of its components with the aging process.

Influência dos odores de gato e de cobra no comportamento defensivo e expressão de fos do sistema hipotalâmico de defesa de camundongo

Studies using neuronal tract-tracer in rat have shown that the anterior hypothalamic nucleus, dorsomedial division of the ventromedial nucleus of the hypothalamus and dorsal premammillary nucleus are highly connected. When the rat is exposed to predator or its odor these nuclei have shown a expression of Fos and their lesion reduces defensive behavior against predator. This set of nuclei was named the Hypothalamic Defense System. However, little is known about the response of this system to the odor of different predators or its role in mice. In this work, we exposed Swiss mice to two different predators odor (cat and snake) to verify the Fos expression in the Hypothalamic Defense System, as well as the defensive behaviors displayed. The analysis showed that the mice exposure to cat odor had an increased expression of Fos protein compared to control, while those exposed to snake odor showed no rise in Fos expression, which was corroborated by the behavioral data. Our results indicate that this distinct circuit in mice seems to act differentially to odorous stimuli of different predators, causing distinct behavioral responses of mice and that the odor of snake seems not to be perceived by Swiss mice as a threatening stimulus.

Papel da proteína de reparo XPC na regulação das proteínas de reparo APE1, OGG1 e PARP-1 em células humanas e de camundongos

studies using UV as a source of DNA damage. However, even though unrepaired UV-induced DNA damages are related to mutagenesis, cell death and tumorigenesis, they do not explain phenotypes such as neurodegeneration and internal tumors observed in patients with syndromes like Xeroderma Pigmentosum (XP) and Cockayne Syndrome (CS) that are associated with NER deficiency. Recent evidences point to a role of NER in the repair of 8-oxodG, a typical substrate of Base Excision Repair (BER). Since deficiencies in BER result in genomic instability, neurodegenerative diseases and cancer, it was investigated in this research the impact of XPC deficiency on BER functions in human cells. It was analyzed both the expression and the cellular localization of APE1, OGG1 e PARP-1, the mainly BER enzymes, in different NER-deficient human fibroblasts. The endogenous levels of these enzymes are reduced in XPC deficient cells. Surprisingly, XP-C fibroblasts were more resistant to oxidative agents than the other NER deficient fibroblasts, despite presenting the highest of 8-oxodG. Furthermore, subtle changes in the nuclear and mitochondrial localization of APE1 were detected in XP-C fibroblasts. To confirm the impact of XPC deficiency in the regulation of APE1 and OGG1 expression and activity, we constructed a XPC-complemented cell line. Although the XPC complementation was only partial, we found that XPC-complemented cells presented increased levels of OGG1 than XPC-deficient cells. The extracts from XPC-complemented cells also presented an elevated OGG1 enzimatic activity. However, it was not observed changes in APE1 expression and activity in the XPCcomplemented cells. In addition, we found that full-length APE1 (37 kDa) and OGG1- α are in the mitochondria of XPC-deficient fibroblasts and XPC-complemented fibroblasts before and after induction of oxidative stress. On the other hand, the expression of APE1 and PARP-1 are not altered in brain and liver of XPC knockout mice. However, XPC deficiency changed the APE1 localization in hypoccampus and hypothalamus. We also observed a physical interaction between XPC and APE1 proteins in human cells. In conclusion, the data suggest that XPC protein has a role in the regulation of OGG1 expression and activity in human cells and is involved mainly in the regulation of APE1 localization in mice. Aditionally, the response of NER deficient cells under oxidative stress may not be only associated to the NER deficiency per se, but it may include the new functions of NER enzymes in regulation of expression and cell localization of BER proteins